Brief: Anavex Life Sciences Terminates A&R Sales Agreement Dated May 1, 2020
30/07/2024 22:56
July 30 (Reuters) - Anavex Life Sciences Corp AVXL.O :
* ANAVEX LIFE SCIENCES: ON JULY 24, TERMINATED A&R SALES
AGREEMENT
DATED MAY 1, 2020
* ANAVEX LIFE SCIENCES CORP: NO PENALTIES ASSOCIATED WITH
TERMINATION OF A&R SALES AGREEMENT
Source text for Eikon: ID:n0001731122-24-001160
Further company coverage: AVXL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anavex Life Sciences
See all newsBrief: Anavex Provides Corporate Update, Announces Completion Of Clinical Conduct Of Adme And Ddi Clinical Studies
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board